Tomé FM - Search Results

1

A homologue of dystrophin is expressed at the neuromuscular junctions of normal individuals and DMD patients, and of normal and mdx mice. Immunological evidence.

Pons F, Augier N, Léger JO, Robert A, Tomé FM, Fardeau M, Voit T, Nicholson LV, Mornet D, Léger JJ. Pons F, et al. Among authors: tome fm. FEBS Lett. 1991 Apr 22;282(1):161-5. doi: 10.1016/0014-5793(91)80468-i. FEBS Lett. 1991. PMID: 1709117 Free article.

2

[Presence of dystrophine-like protein at the neuromuscular junction in Duchenne muscular dystrophy and in "mdx" mutant mice].

Fardeau M, Tomé FM, Collin H, Augier N, Pons F, Léger J, Léger J. Fardeau M, et al. Among authors: tome fm. C R Acad Sci III. 1990;311(5):197-204. C R Acad Sci III. 1990. PMID: 2119867 French.

3

Nebulin seen in DMD males including one patient with a large DNA deletion encompassing the DMD gene.

Pernelle JJ, Chafey P, Chelly J, Wahrmann JP, Kaplan JC, Tomé F, Fardeau M. Pernelle JJ, et al. Hum Genet. 1988 Mar;78(3):285. doi: 10.1007/BF00291678. Hum Genet. 1988. PMID: 3346018

4

Storage of phosphorylated desmin in a familial myopathy.

Rappaport L, Contard F, Samuel JL, Delcayre C, Marotte F, Tomè F, Fardeau M. Rappaport L, et al. FEBS Lett. 1988 Apr 25;231(2):421-5. doi: 10.1016/0014-5793(88)80863-9. FEBS Lett. 1988. PMID: 3360147 Free article.

5

Immunocytochemical analysis of myosin heavy chains in human fetal skeletal muscles.

Pons F, Léger JO, Chevallay M, Tomé FM, Fardeau M, Léger JJ. Pons F, et al. Among authors: tome fm. J Neurol Sci. 1986 Dec;76(2-3):151-63. doi: 10.1016/0022-510x(86)90165-6. J Neurol Sci. 1986. PMID: 3540217

6

Expression of dystrophin-associated glycoproteins during human fetal muscle development: a preliminary immunocytochemical study.

Tomé FM, Matsumura K, Chevallay M, Campbell KP, Fardeau M. Tomé FM, et al. Neuromuscul Disord. 1994 Jul;4(4):343-8. doi: 10.1016/0960-8966(94)90070-1. Neuromuscul Disord. 1994. PMID: 7981591

7

Ultrastructure of muscle and neuromuscular junction: an historical survey of the early French contributions.

Fardeau M, Tomé FM. Fardeau M, et al. Among authors: tome fm. Biol Cell. 1994;80(2-3):115-7. doi: 10.1111/j.1768-322x.1994.tb00918.x. Biol Cell. 1994. PMID: 8087060 Review. No abstract available.

8

Ubiquitin and beta-amyloid-protein in inclusion body myositis (IBM), familial IBM-like disorder and oculopharyngeal muscular dystrophy: an immunocytochemical study.

Leclerc A, Tomé FM, Fardeau M. Leclerc A, et al. Among authors: tome fm. Neuromuscul Disord. 1993 Jul;3(4):283-91. doi: 10.1016/0960-8966(93)90021-b. Neuromuscul Disord. 1993. PMID: 8268725

9

Oculopharyngeal muscular dystrophy in France.

Fardeau M, Tomé FM. Fardeau M, et al. Among authors: tome fm. Neuromuscul Disord. 1997 Oct;7 Suppl 1:S30-3. doi: 10.1016/s0960-8966(97)00078-3. Neuromuscul Disord. 1997. PMID: 9392012

10

Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization?

Récan D, Chafey P, Leturcq F, Hugnot JP, Vincent N, Tomé F, Collin H, Simon D, Czernichow P, Nicholson LV, et al. Récan D, et al. J Clin Invest. 1992 Feb;89(2):712-6. doi: 10.1172/JCI115640. J Clin Invest. 1992. PMID: 1737859 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters